Consider New Nuplazid for Some Patients With Parkinson's Psychosis

August 2016

The new antipsychotic, Nuplazid (new-PLAH-zid, pimavanserin), will raise questions about treating psychotic symptoms in Parkinson's patients.

Psychosis is common in Parkinson's...partly because the meds used to improve tremors and stiffness may cause hallucinations and delusions.

But antipsychotics block dopamine and can worsen motor function.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote